Amylin accumulation may serve as heart failure marker in diabetes

03/4/2012 | Endocrine Today

Obese patients and type 2 diabetes patients with heart failure appeared to have greater accumulation of large amylin oligomers, fibrils and plaques compared with participants with normal hearts or those with heart failure who were not obese or did not have diabetes, a study in Circulation Research found. Inhibiting the circulation of large amylin oligomers from the pancreas to the heart may help predict and prevent the onset of heart failure in people with prediabetes, a researcher said.

View Full Article in:

Endocrine Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC